Clinical Trial Update: Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study evaluating malathion gel 0.5% and malathion 0.5% lotion (Ovide) in patients with head lice has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pediculosis Capitis

Drugs mentioned

• Malathion 0.5% Lotion (Ovide) (malathion)
• Malathion gel 0.5% (malathion)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Pediculosis | Phase 1 | Status: COMPLETED